The mechanisms of pharmacokinetic food-drug interactions – A perspective from the UNGAP group

Abrahamsson, 2004, Food effects on tablet disintegration, Eur. J. Pharm. Sci., 22, 165, 10.1016/j.ejps.2004.03.004 Abuajah, 2015, Functional components and medicinal properties of food: a review, J. Food Sci. Technol., 52, 2522, 10.1007/s13197-014-1396-5 Adiwidjaja, 2017, Curcumin as a clinically-promising anti-cancer agent: pharmacokinetics and drug interactions, Exp. Opin. Drug Metab. Toxicol., 13, 953, 10.1080/17425255.2017.1360279 Albassam, 2017, An appraisal of drug-drug interactions with green tea (Camellia sinensis), Planta Med., 83, 496, 10.1055/s-0043-100934 Al-Salami, 2008, Probiotic pre-treatment reduces gliclazide permeation (ex vivo) in healthy rats but increases it in diabetic rats to the level seen in untreated healthy rats, Arch. Drug Inf., 1, 35, 10.1111/j.1753-5174.2008.00006.x Ameer, 1997, Drug interactions with grapefruit juice, Clin. Pharmacokinet., 33, 103, 10.2165/00003088-199733020-00003 Amidon, 1995, A theoretical basis for a biopharmaceutic drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability, Pharm. Res., 12, 413, 10.1023/A:1016212804288 Anguizola, 2013, Effects of fatty acids and glycation on drug interactions with human serum albumin, Curr. Metabolomics, 1, 239, 10.2174/2213235X1130100005 Armand, 2004, Gastric function in children with cystic fibrosis: effect of diet on gastric lipase levels and fat digestion, Pediatr. Res., 55, 457, 10.1203/01.PDR.0000110522.78194.5B Arora, 2000, Modulation of liposomal membrane fluidity by flavonoids and isoflavonoids, Arch. Biochem. Biophys., 373, 102, 10.1006/abbi.1999.1525 Artursson, 1999, Paracellular drug transport across intestinal epithelia: influence of charge and induced water flux, Eur. J. Pharm. Sci., 9, 47, 10.1016/S0928-0987(99)00041-X Ascenzi, 2014, Clinical relevance of drug binding to plasma proteins, J. Mol. Struct., 1077, 4, 10.1016/j.molstruc.2013.09.053 Bahramsoltani, 2017, Pharmacokinetic interactions of curcuminoids with conventional drugs: a review, J. Ethnopharmacol., 209, 1, 10.1016/j.jep.2017.07.022 Bailey, 1998, Grapefruit juice-drug interactions. Br, J. Clin. Pharmacol., 46, 101, 10.1046/j.1365-2125.1998.00764.x Baraka-Vidot, 2015, Glycation alters ligand binding, enzymatic, and pharmacological properties of human albumin, Biochem, 54, 3051, 10.1021/acs.biochem.5b00273 Basheer, 2015, Interactions between CYP3A4 and dietary polyphenols, Oxidative Med. Cell. Longev., 2015, 1, 10.1155/2015/854015 Bennet, 2018, Multivariate modelling of faecal bacterial profiles of patients with IBS predicts responsiveness to a diet low in FODMAPs, Gut, 67, 872, 10.1136/gutjnl-2016-313128 Bernier-Latmani, 2017, Intestinal lymphatic vasculature: structure, mechanisms and functions, Nat. Rev. Gastroenterol. Hepatol., 14, 510, 10.1038/nrgastro.2017.79 Bogentoft, 1978, Influence of food on the absorption of acetylsalicylic acid from enteric-coated dosage forms, Eur. J. Clin. Pharmacol., 14, 351, 10.1007/BF00611905 Brandsch, 2013, Drug transport via the intestinal peptide transporter PepT1, Curr. Opin. Pharmacol., 13, 881, 10.1016/j.coph.2013.08.004 Brocks, 2006, The effect of increased lipoprotein levels on the pharmacokinetics of cyclosporine A in the laboratory rat, Biopharm. Drug Dispos., 27, 7, 10.1002/bdd.476 Brodin, 2002, Transport of peptidomimetic drugs by the intestinal di/tri-peptide transporter, PepT1, Pharmacol. Toxicol., 10.1034/j.1600-0773.2002.900601.x Brown, 1989, The monoamine oxidase inhibitor-tyramine interaction, J. Clin. Pharmacol., 29, 529, 10.1002/j.1552-4604.1989.tb03376.x Caliph, 2009, Oral bioavailability assessment and intestinal lymphatic transport of Org 45697 and Org 46035, two highly lipophilic novel immunomodulator analogues, Curr. Drug Deliv., 6, 359, 10.2174/156720109789000500 Caliph, 2000, Effect of short-, medium-, and long-chain fatty acid-based vehicles on the absolute oral bioavailability and intestinal lymphatic transport of halofantrine and assessment of mass balance in lymph-cannulated and non-cannulated rats, J. Pharm. Sci., 89, 1073, 10.1002/1520-6017(200008)89:8<1073::AID-JPS12>3.0.CO;2-V Caliph, 2013, The impact of lymphatic transport on the systemic disposition of lipophilic drugs, J. Pharm. Sci., 102, 2395, 10.1002/jps.23597 Camilleri, 1989, Human gastric emptying and colonic filling characterized by a new method of solids, Am. J. Physiol. Gastrointest. Liver Physiol., 257, G284, 10.1152/ajpgi.1989.257.2.G284 Carver, 1999, Meal composition effects on the oral bioavailability of Indinavir in HIV-infected patients, Pharm. Res., 16, 718, 10.1023/A:1018880726035 Chaddock, 2014, Novel MRI tests of orocecal transit time and whole gut transit time: studies in normal subjects, Neurogastroenterol. Motil., 26, 205, 10.1111/nmo.12249 Chalet, 2018, Intestinal disposition of quercetin and its phase-II metabolites after oral administration in healthy volunteers, J. Pharm. Pharmacol., 70, 1002, 10.1111/jphp.12929 Challenor, 1987, Food and nifedipine pharmacokinetics, Br. J. Clin. Pharmacol., 23, 248, 10.1111/j.1365-2125.1987.tb03040.x Chan, 2017, An evaluation of optimal PEGylation strategies for maximizing the lymphatic exposure and antiviral activity of interferon after subcutaneous administration, Biomacromolecules, 18, 2866, 10.1021/acs.biomac.7b00794 Charman, 1986, Estimating the maximal potential for intestinal lymphatic transport of lipophilic drug molecules, Int. J. Pharm., 34, 175, 10.1016/0378-5173(86)90027-X Clayton, 2006, Pharmaco-metabonomic phenotyping and personalized drug treatment, Nature, 440, 1073, 10.1038/nature04648 Cole, 2004, In vitro and in vivo pharmacoscintigraphic evaluation of ibuprofen hypromellose and gelatin capsules, Pharm. Res., 21, 793, 10.1023/B:PHAM.0000026430.73789.e6 Corsetti, 2018, First “translational” consensus on terminology and definition of colonic motility as studied in humans and animals by means of manometric and non-manometric techniques, Nat. Rev. Gastroenterol. Hepatol. Custodio, 2008, Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption, Adv. Drug Deliv. Rev., 60, 717, 10.1016/j.addr.2007.08.043 Cvijić, 2014, Viscosity-mediated negative food effect on oral absorption of poorly-permeable drugs with an absorption window in the proximal intestine: in vitro experimental simulation and computational verification, Eur. J. Pharm. Sci., 61, 40, 10.1016/j.ejps.2014.04.008 Dahan, 2004, Food–drug interaction: grapefruit juice augments drug bioavailability—mechanism, extent and relevance, Eur. J. Clin. Nutr., 58, 1, 10.1038/sj.ejcn.1601736 Dai, 2015, Consuming Lentinula edodes (shiitake) mushrooms daily improves human immunity: a randomized dietary intervention in healthy young adults, J. Am. Coll. Nutr., 34, 478, 10.1080/07315724.2014.950391 David, 2014, Diet rapidly and reproducibly alters the human gut microbiome, Nature, 505, 559, 10.1038/nature12820 Davis, 2009, Scintigraphic study to investigate the effect of food on a HPMC modified release formulation of UK-294,315, J. Pharm. Sci., 98, 1568, 10.1002/jps.21507 Davis, 1986, Transit of pharmaceutical dosage forms through the small intestine, Gut, 27, 886, 10.1136/gut.27.8.886 Debersac, 2001, Effects of a water-soluble extract of rosemary and its purified component rosmarinic acid on xenobiotic-metabolizing enzymes in rat liver, Food Chem. Toxicol., 39, 109, 10.1016/S0278-6915(00)00117-4 Deloose, 2012, The migrating motor complex: control mechanisms and its role in health and disease, Nat. Rev. Gastroenterol. Hepatol., 9, 271, 10.1038/nrgastro.2012.57 Demirkan, 2017, Assessment of drug administration via feeding tube and the knowledge of health-care professionals in a university hospital, Eur. J. Clin. Investig., 71, 164 Detampel, 2012, Drug interaction potential of resveratrol, Drug Metab. Rev., 44, 253, 10.3109/03602532.2012.700715 Di Pierro, 2012, Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control, Diabet. Metab. Syndr. Obes., 5, 213, 10.2147/DMSO.S33718 Diakidou, 2009, Estimation of intragastric drug solubility in the fed state: comparison of various media with data in aspirates, Biopharm. Drug Dispos., 30, 318, 10.1002/bdd.670 Didziapetris, 2003, Classification analysis of P-glycoprotein substrate specificity, J. Drug Target., 11, 391, 10.1080/10611860310001648248 Digenis, 1990, Gastrointestinal behavior of orally administered radiolabeled erythromycin pellets in man as determined by gamma scintigraphy, J. Clin. Pharmacol., 30, 621, 10.1002/j.1552-4604.1990.tb01865.x Digenis, 2000, Bioequivalence study of stressed and nonstressed hard gelatin capsules using amoxicillin as a drug marker and gamma scintigraphy to confirm time and GI location of in vivo capsule rupture, Pharm. Res., 17, 572, 10.1023/A:1007568900147 Dixon, 2010, Lymphatic lipid transport: sewer or subway?, Trends Endocrinol. Metab., 21, 480, 10.1016/j.tem.2010.04.003 Dresser, 2000, Pharmacokinetic-pharmacodynamic consequences and clinical relevance of cytochrome P450 3A4 inhibition, Clin. Pharmacokinet., 38, 41, 10.2165/00003088-200038010-00003 Dresser, 2002, Fruit juices inhibit organic anion transporting polypeptide-mediated drug uptake to decrease the oral availability of fexofenadine, Clin. Pharmacol. Ther., 71, 11, 10.1067/mcp.2002.121152 Dresser, 2005, Effect of grapefruit juice volume on the reduction of fexofenadine bioavailability: possible role of organic anion transporting polypeptides, Clin. Pharmacol. Ther., 77, 170, 10.1016/j.clpt.2004.10.005 Drozdzik, 2018, Protein abundance of clinically relevant drug-metabolizing enzymes in the human liver and intestine: a comparative analysis in paired tissue specimens, Clin. Pharmacol. Ther., 104, 515, 10.1002/cpt.967 Dudley, 1991, The effect of food or milk on the absorption kinetics of ofloxacin, Eur. J. Clin. Pharmacol., 41, 569, 10.1007/BF00314986 Duffy, 2000, Prediction of properties from simulations: free energies of solvation in hexadecane, octanol, and water, J. Am. Chem. Soc., 122, 2878, 10.1021/ja993663t Dvorackova, 2013, Targeting of drugs into colon, Chem. List., 107, 522 Edelbroek, 1993, Effects of erythromycin on gastric emptying, alcohol absorption and small intestinal transit in normal subjects, J. Nucl. Med., 34, 582 Edwards, 1999, 6′,7′-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein, Clin. Pharmacol. Ther., 65, 237, 10.1016/S0009-9236(99)70102-5 Eldin, 2010, Preliminary study of the clinical hypoglycemic effects of Allium cepa (red onion) in type 1 and type 2 diabetic patients, Env. Heal. Insights, 4, 71 Enright, 2016, The impact of the gut microbiota on drug metabolism and clinical outcome, Yale J. Biol. Med, 89, 375 Enright, 2017, Impact of gut microbiota-mediated bile acid metabolism on the solubilization capacity of bile salt micelles and drug solubility, Mol. Pharm., 14, 1251, 10.1021/acs.molpharmaceut.6b01155 Erokhova, 2016, The sodium glucose cotransporter SGLT1 is an extremely efficient facilitator of passive water transport, J. Biol. Chem., 291, 9712, 10.1074/jbc.M115.706986 European Medicines Agency (EMA) European Medicines Agency (EMA), 2012 European Medicines Agency (EMA) European Medicines Agency (EMA) European Medicines Agency (EMA) European Medicines Agency (EMA) Fadda, 2009, Meal-induced acceleration of tablet transit through the human small intestine, Pharm. Res., 26, 356, 10.1007/s11095-008-9749-2 Fagerberg, 2012, Ethanol effects on apparent solubility of poorly soluble drugs in simulated intestinal fluid, Mol. Pharm., 9, 1942, 10.1021/mp2006467 Fagerberg, 2015, Concomitant intake of alcohol may increase the absorption of poorly soluble drugs, Eur. J. Pharm. Sci., 67, 12, 10.1016/j.ejps.2014.10.017 Famurewa, 2017, Virgin coconut oil supplementation attenuates acute chemotherapy hepatotoxicity induced by anticancer drug methotrexate via inhibition of oxidative stress in rats, Biomed. Pharmacother., 87, 437, 10.1016/j.biopha.2016.12.123 Farkas, 2008, Influence of fruit juices on drug disposition: discrepancies between in vitro and clinical studies, Exp. Opin. Drug Metab. Toxicol., 4, 381, 10.1517/17425255.4.4.381 Farré, 2013, Food and symptom generation in functional gastrointestinal disorders: physiological aspects, Am. J. Gastroenterol., 108, 698, 10.1038/ajg.2013.24 Fenner, 2009, Drug-drug interactions mediated through P-glycoprotein: clinical relevance and in vitro-in vivo correlation using digoxin as a probe drug, Clin. Pharmacol. Ther., 85, 173, 10.1038/clpt.2008.195 Fleisher, 1999, Drug, meal and formulation interactions influencing drug absorption after oral administration: clinical implications, Clin. Pharmacokinet., 36, 233, 10.2165/00003088-199936030-00004 Fletcher, 2014, Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues, Proc. Natl. Acad. Sci., 111, 2307, 10.1073/pnas.1318249111 Food and drug Administration (FDA) Freudenthaler, 1998, Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism, Br. J. Clin. Pharmacol., 46, 541, 10.1046/j.1365-2125.1998.00819.x Friedlander, 1990, Increase in membrane fluidity modulates sodium-coupled uptakes and cyclic AMP synthesis by renal proximal tubular cells in primary culture, Biochim. Biophys. Acta, 1022, 1, 10.1016/0005-2736(90)90393-3 Fritz, 2018, Expression of clinically relevant drug-metabolizing enzymes along the human intestine and their correlation to drug transporters and nuclear receptors: an intra-subject analysis, Basic Clin. Pharmacol. Toxicol., 00, 1 Frost, 1989, Ciprofloxacin pharmacokinetics after a standard or high-fat/high-calcium breakfast, J. Clin. Pharmacol., 29, 953, 10.1002/j.1552-4604.1989.tb03260.x Fuchikami, 2006, Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B, Drug Metab. Dispos., 34, 577, 10.1124/dmd.105.007872 Fujii, 2011, Enteric-coated tablets improve oral bioavailability of DX-9065, a novel anticoagulant, Eur. J. Pharm. Sci., 42, 392, 10.1016/j.ejps.2011.01.003 Galetin, 2010, Contribution of intestinal cytochrome p450-mediated metabolism to drug-drug inhibition and induction interactions, Drug Metab. Pharmacokinet., 25, 28, 10.2133/dmpk.25.28 Garbacz, 2010, A biorelevant dissolution stress test device - background and experiences, Expert Opin. Drug Deliv., 7, 1251, 10.1517/17425247.2010.527943 Garbacz, 2014, Release characteristics of quetiapine fumarate extended release tablets under biorelevant stress test conditions, AAPS PharmSciTech, 15, 230, 10.1208/s12249-013-0050-2 Geirnaert, 2017, Butyrate-producing bacteria supplemented in vitro to Crohn's disease patient microbiota increased butyrate production and enhanced intestinal epithelial barrier integrity, Sci. Rep., 7, 10.1038/s41598-017-11734-8 Gershkovich, 2007, Effect of a high-fat meal on absorption and disposition of lipophilic compounds: the importance of degree of association with triglyceride-rich lipoproteins, Eur. J. Pharm. Sci., 32, 24, 10.1016/j.ejps.2007.05.109 Gershkovich, 2007, Different impacts of intestinal lymphatic transport on the oral bioavailability of structurally similar synthetic lipophilic cannabinoids: Dexanabinol and PRS-211,220, Eur. J. Pharm. Sci., 31, 298, 10.1016/j.ejps.2007.04.006 Gershkovich, 2007, The effect of a high-fat meal on the pharmacodynamics of a model lipophilic compound that binds extensively to triglyceride-rich lipoproteins, Int. J. Pharm., 333, 1, 10.1016/j.ijpharm.2007.01.012 Glaeser, 2004, Impact of concentration and rate of intraluminal drug delivery on absorption and gut wall metabolism of verapamil in humans, Clin. Pharmacol. Ther., 76, 230, 10.1016/j.clpt.2004.04.013 Glaeser, 2007, Intestinal drug transporter expression and the impact of grapefruit juice in humans, Clin. Pharmacol. Ther., 81, 362, 10.1038/sj.clpt.6100056 Goetze, 2006, Funktionelle Magnetresonanzbildgebung des Verdauungstraktes, Internist, 47, 28, 10.1007/s00108-005-1527-1 Goetze, 2007, The effect of macronutrients on gastric volume responses and gastric emptying in humans: a magnetic resonance imaging study, Am. J. Physiol. Gastrointest. Liver Physiol., 292, G11, 10.1152/ajpgi.00498.2005 Gorski, 2003, The effect of age, sex, and rifampin administration on intestinal and hepatic cytochrome P450 3A activity, Clin. Pharmacol. Ther., 74, 275, 10.1016/S0009-9236(03)00187-5 Graffner, 1986, Intra- and intersubject variation of erythromycin absorption from single-unit and multiple-unit enteric-coated products, Biopharm. Drug Dispos., 7, 163, 10.1002/bdd.2510070207 Greenwood, 1994 Grimm, 2017, Gastric water emptying under fed state clinical trial conditions is as fast as under fasted conditions, Mol. Pharm., 14, 4262, 10.1021/acs.molpharmaceut.7b00623 Grimm, 2018, Interindividual and intraindividual variability of fasted state gastric fluid volume and gastric emptying of water, Eur. J. Pharm. Biopharm., 127, 309, 10.1016/j.ejpb.2018.03.002 Grimm, 2018, Gastric emptying and small bowel water content after administration of grapefruit juice compared to water and isocaloric solutions of glucose and fructose: a four-way crossover MRI pilot study in healthy subjects, Mol. Pharm., 15, 548, 10.1021/acs.molpharmaceut.7b00919 Gufford, 2015, Milk thistle constituents inhibit raloxifene intestinal glucuronidation: a potential clinically relevant natural product-drug interaction, Drug Metab. Dispos., 43, 1353, 10.1124/dmd.115.065086 Guimarães, 2018, Biopharmaceutical considerations in paediatrics with a view to the evaluation of orally administered drug products - a PEARRL review, J. Pharm. Pharmacol. Gul, 2016, Nutraceuticals and functional foods: the foods for the future world, Crit. Rev. Food Sci. Nutr., 56, 2617, 10.1080/10408398.2014.903384 Gunnarsson, 1990, Impairment of estramustine phosphate absorption by concurrent intake of milk and food, Eur. J. Clin. Pharmacol., 38, 189, 10.1007/BF00265983 Gurley, 2012, Pharmacokinetic herb-drug interactions (part 2): drug interactions involving popular botanical dietary supplements and their clinical relevance, Planta Med., 78, 1490, 10.1055/s-0031-1298331 Gurley, 2012, Pharmacokinetic herb-drug interactions (part 1): origins, mechanisms, and the impact of botanical dietary supplements, Planta Med., 78, 1478, 10.1055/s-0031-1298273 Gurley, 2002, Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans*, Clin. Pharmacol. Ther., 72, 276, 10.1067/mcp.2002.126913 Hagenbuch, 2003, The superfamily of organic anion transporting polypeptides, Biochim. Biophys. Acta, 1609, 1, 10.1016/S0005-2736(02)00633-8 Hakooz, 2007, Effects of dietary broccoli on human in vivo caffeine metabolism: a pilot study on a group of Jordanian volunteers, Curr. Drug Metab., 8, 9, 10.2174/138920007779315080 Hanselin, 2010, INR elevation with Maitake extract in combination with warfarin, Ann. Pharmacother., 44, 223, 10.1345/aph.1M510 Harris, 2003, Dietary effects on drug metabolism and transport, Clin. Pharmacokinet., 42, 1071, 10.2165/00003088-200342130-00001 Hasler, 2002, Functional foods: benefits, concerns and challenges — a position paper from the American council on science and health, J. Nutr., 132, 3772, 10.1093/jn/132.12.3772 Haw, 2010, Administration of medicines in food and drink: a study of older inpatients with severe mental illness, Int. Psychogeriatr., 22, 409, 10.1017/S1041610209991669 Hayes, 1977, Ethanol and oral diazepam absorption, New Engl. J. Med., 296, 186, 10.1056/NEJM197701272960402 Henderson, 2002, St John's wort (Hypericum perforatum): drug interactions and clinical outcomes, Br. J. Clin. Pharmacol., 54, 349, 10.1046/j.1365-2125.2002.01683.x Hens, 2017, Low buffer capacity and alternating motility along the human gastrointestinal tract: implications for in vivo dissolution and absorption of ionizable drugs, Mol. Pharm., 14, 4281, 10.1021/acs.molpharmaceut.7b00426 Hilgendorf, 2007, Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines, Drug Metab. Dispos., 35, 1333, 10.1124/dmd.107.014902 Ho, 2010, Effects of garlic on cytochromes P450 2C9- and 3A4-mediated drug metabolism in human hepatocytes, Sci. Pharm., 78, 473, 10.3797/scipharm.1002-11 Hoad, 2007, Non-invasive quantification of small bowel water content by MRI: a validation study, Phys. Med. Biol., 52, 6909, 10.1088/0031-9155/52/23/009 Holm, 2001, Comparison of the lymphatic transport of halofantrine administered in disperse systems containing three different unsaturated fatty acids, Pharm. Res., 18, 1299, 10.1023/A:1013037927882 Holtbecker, 1996, The nifedipine-rifampin interaction. Evidence for induction of gut wall metabolism, Drug Metab. Dispos., 24, 1121 Hoogkamer, 1995, The effect of milk consumption on the pharmacokinetics of fleroxacin and ciprofloxacin in healthy volunteers, Drugs, 49, 346, 10.2165/00003495-199500492-00094 Hou, 2015, Garlic intake lowers fasting blood glucose: meta-analysis of randomized controlled trials, Asia Pac. J. Clin. Nutr., 24, 575 Hou, 2008, Structure – ADME relationship: still a long way to go?, Exp. Opin. Drug Metab. Toxicol., 4, 759, 10.1517/17425255.4.6.759 Huang, S.-M., Strong, J.M., Zhang, L., Reynolds, K.S., Nallani, S., Temple, R., Abraham, S., Al Habet, S., Baweja, R.K., Burckart, G.J., Chung, S., Colangelo, P., Frucht, D., Green, M.D., Hepp, P., Karnaukhova, E., Ko, H.-S., Lee, J.-I., Marroum, P.J., Norden, J.M., Qiu, W., Rahman, A., Sobel, S., Stifano, T., Thummel, K., Wei, X.-X., Yasuda, S., Zheng, J.H., Zhao, H., Lesko, L.J., 2008. New era in drug interaction evaluation: US Food and Drug Administration update on CYP enzymes, transporters, and the guidance process. J. Clin. Pharmacol. 48, 662–670. doi:https://doi.org/10.1177/0091270007312153. Huang, 2013, Effect of alpha-1-acid glycoprotein binding on pharmacokinetics and pharmacodynamics, Curr. Drug Metab., 14, 226 Hubbard, 2006, Ingestion of onion soup high in quercetin inhibits platelet aggregation and essential components of the collagen-stimulated platelet activation pathway in man: a pilot study, Br. J. Nutr., 96, 482 Hussein, 2015, Fat emulsion intragastric stability and droplet size modulate gastrointestinal responses and subsequent food intake in young adults 1 – 4, J. Nutr., 1 Imanaga, 2011, The effects of the SLCO2B1 c.1457C>T polymorphism and apple juice on the pharmacokinetics of fexofenadine and midazolam in humans, Pharmacogenet. Genomics, 21, 84, 10.1097/FPC.0b013e32834300cc Ingels, 2004, Effect of simulated intestinal fluid on drug permeability estimation across Caco-2 monolayers, Int. J. Pharm., 274, 221, 10.1016/j.ijpharm.2004.01.014 Israili, 2001, Human alpha-1-glycoprotein and its interactions with drugs, Drug Metab. Rev., 33, 161, 10.1081/DMR-100104402 Jain, 2014, The influence of hydroxypropyl methylcellulose (HPMC) molecular weight, concentration and effect of food on in vivo erosion behavior of HPMC matrix tablets, J. Control. Release, 187, 50, 10.1016/j.jconrel.2014.04.058 Janssen, 2011, Review article: the role of gastric motility in the control of food intake, Aliment. Pharmacol. Ther., 33, 880, 10.1111/j.1365-2036.2011.04609.x Jensen, 1995, Introduction, 1 Johansson, 1983, Opposite effects of carbohydrate and protein on phenytoin absorption in man, Drug Nutr. Interact, 2, 139 Johnson, 2012, Effects of alcohol on the pharmacokinetics of morphine sulfate and naltrexone hydrochloride extended release capsules, J. Clin. Pharmacol., 52, 747, 10.1177/0091270011403740 Jones, 2012, The disintegration behaviour of capsules in fed subjects: a comparison of hypromellose (carrageenan) capsules and standard gelatin capsules, Int. J. Pharm., 424, 40, 10.1016/j.ijpharm.2011.12.034 Jukic, 2007, In vitro acetylcholinesterase inhibitory properties of thymol, carvacrol and their derivatives thymoquinone and thymohydroquinone, Phytother. Res., 21, 259, 10.1002/ptr.2063 Jung, 1997, The influence of coffee with milk and tea with milk on the bioavailability of tetracycline, Biopharm. Drug Dispos., 18, 459, 10.1002/(SICI)1099-081X(199707)18:5<459::AID-BDD31>3.0.CO;2-G Kahela, 1979, Effect of food, food constituents and fluid volume on the bioavailability of sotalol, Acta Pharmacol. Toxicol., 44, 7, 10.1111/j.1600-0773.1979.tb02288.x Kala, 2012, Covert medication; the last option: a case for taking it out of the closet and using it selectively, Indian J. Psychiatry, 54, 257, 10.4103/0019-5545.102427 Kalima, 1996, Lactobacillus rhamnosus infection in a child following bone marrow transplant, J. Inf. Secur., 32, 165 Kaminskas, 2013, PEGylation of interferon α2 improves lymphatic exposure after subcutaneous and intravenous administration and improves antitumour efficacy against lymphatic breast cancer metastases, J. Control. Release, 168, 200, 10.1016/j.jconrel.2013.03.006 Kang, 2013, The effect of gut microbiota on drug metabolism, Exp. Opin. Drug Metab. Toxicol., 9, 1295, 10.1517/17425255.2013.807798 Kang, 2010, Inconsistent labeling of food effect for oral agents across therapeutic areas: differences between oncology and non-oncology products, Clin. Cancer Res., 16, 4446, 10.1158/1078-0432.CCR-10-0663 Karim, 1985, Food-induced changes in theophylline absorption from controlled-release formulations. Part I. Substantial increased and decreased absorption with Uniphyl tablets and Theo-Dur sprinkle, Clin. Pharmacol. Ther., 38, 77, 10.1038/clpt.1985.138 Kelly, 2003, Comparison of the rates of disintegration, gastric emptying, and drug absorption following administration of a new and a conventional paracetamol formulation, using gamma scintigraphy, Pharm. Res., 20, 1668, 10.1023/A:1026155822121 Keppler, 2011, 299 Khoo, 2002, A physicochemical basis for the extensive intestinal lymphatic transport of a poorly lipid soluble antimalarial, halofantrine hydrochloride, after postprandial administration to dogs, J. Pharm. Sci., 91, 647, 10.1002/jps.10045 Khoo, 2003, Intestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogs, Pharm. Res., 20, 1460, 10.1023/A:1025718513246 Klein, 2004, Media to simulate the postprandial stomach I. Matching the physicochemical characteristics of standard breakfasts, J. Pharm. Pharmacol., 56, 605, 10.1211/0022357023367 Kobayashi, 2003, Involvement of human organic anion transporting polypeptide OATP-B (SLC21A9) in pH-dependent transport across intestinal apical membrane, J. Pharmacol. Exp. Ther., 306, 703, 10.1124/jpet.103.051300 Koch, 2009, Effects of food on the relative bioavailability of lapatinib in cancer patients, J. Clin. Oncol., 27, 1191, 10.1200/JCO.2008.18.3285 Konishi, 2004, A bitter melon extract inhibits the P-glycoprotein activity in intestinal Caco-2 cells: monoglyceride as an active compound, Biofactors, 22, 71, 10.1002/biof.5520220113 Konishi, 2004, Inhibitory effect of a bitter melon extract on the P-glycoprotein activity in intestinal Caco-2 cells, Br. J. Pharmacol., 143, 379, 10.1038/sj.bjp.0705804 Konno, 2001, A possible hypoglycaemic effect of maitake mushroom on Type 2 diabetic patients, Diabet. Med., 18, 10.1046/j.1464-5491.2001.00532-5.x Koven, 2012, The effect of fasting and refeeding on mRNA expression of PepT1 and gastrointestinal hormones regulating digestion and food intake in zebrafish (Danio rerio), Fish Physiol. Biochem., 38, 1565, 10.1007/s10695-012-9649-6 Koziolek, 2013, Simulating the postprandial stomach: physiological considerations for dissolution and release testing, Mol. Pharm., 10, 1610, 10.1021/mp300604u Koziolek, 2014, Development of a bio-relevant dissolution test device simulating mechanical aspects present in the fed stomach, Eur. J. Pharm. Sci., 57, 250, 10.1016/j.ejps.2013.09.004 Koziolek, 2014, Intragastric volume changes after intake of a high-caloric, high-fat standard breakfast in healthy human subjects investigated by MRI, Mol. Pharm., 11, 1632, 10.1021/mp500022u Koziolek, 2015, Investigation of pH and temperature profiles in the GI tract of fasted human subjects using the Intellicap® system, J. Pharm. Sci., 104, 2855, 10.1002/jps.24274 Koziolek, 2015, Intragastric pH and pressure profiles after intake of the high-caloric, high-fat meal as used for food effect studies, J. Control. Release, 220, 71, 10.1016/j.jconrel.2015.10.022 Koziolek, 2016, Navigating the human gastrointestinal tract for oral drug delivery: uncharted waters and new frontiers, Adv. Drug Deliv. Rev., 101, 75, 10.1016/j.addr.2016.03.009 Koziolek, 2018, Physiological considerations and in vitro strategies for evaluating the influence of food on drug release from extended-release formulations, AAPS PharmSciTech, 19, 2885, 10.1208/s12249-018-1159-0 Kyrklund, 2000, Rifampin greatly reduces plasma simvastatin and simvastatin acid concentrations, Clin. Pharmacol. Ther., 68, 592, 10.1067/mcp.2000.111414 Läer, 1997, Interaction between sotalol and an antacid preparation, Br. J. Clin. Pharmacol., 43, 269, 10.1046/j.1365-2125.1997.00506.x Lambert, 2007, Metabolism of dietary polyphenols and possible interactions with drugs, Curr. Drug Metab., 8, 499, 10.2174/138920007780866870 Lawless, 2015, Exploring the impact of drug properties on the extent of intestinal lymphatic transport - in vitro and in vivo studies, Pharm. Res., 32, 1817, 10.1007/s11095-014-1578-x Ledergerber, 1985, Effect of standard breakfast on drug absorption and multiple-dose pharmacokinetics of ciprofloxacin, Antimicrob. Agents Chemother., 27, 350, 10.1128/AAC.27.3.350 Lee, 2015, Gut microbiota and tacrolimus dosing in kidney transplantation, PLoS One, 10 Lee, 2018, Piperine-mediated drug interactions and formulation strategy for piperine: recent advances and future perspectives, Expert Opin. Drug Metab. Toxicol., 14, 43, 10.1080/17425255.2018.1418854 Lee, 2017, ILSI Southeast Asia region conference proceedings: the gut, its microbes and health: relevance for Asia, Asia Pac. J. Clin. Nutr., 26, 957 Lehto, 1995, Effects of milk and food on the absorption of enoxacin, Br. J. Clin. Pharmacol., 39, 194, 10.1111/j.1365-2125.1995.tb04431.x de Lemos, 2007, Interaction between mercaptopurine and milk, J. Oncol. Pharm. Pr., 13, 237, 10.1177/1078155207080802 Lennernäs, 2009, Ethanol-drug absorption interaction: potential for a significant effect on the plasma pharmacokinetics of ethanol vulnerable formulations, Mol. Pharm., 6, 1429, 10.1021/mp9000876 Lennernäs, 1994, Intestinal drug absorption during induced net water absorption in man; a mechanistic study using antipyrine, atenolol and enalaprilat, Br. J. Clin. Pharmacol., 37, 589, 10.1111/j.1365-2125.1994.tb04309.x Lentz, 2008, Current methods for predicting human food effect, AAPS J., 10, 282, 10.1208/s12248-008-9025-8 Leslie, 2005, Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defense, Toxicol. Appl. Pharmacol., 204, 216, 10.1016/j.taap.2004.10.012 Lespine, 2006, Contribution of lymphatic transport to the systemic exposure of orally administered moxidectin in conscious lymph duct-cannulated dogs, Eur. J. Pharm. Sci., 27, 37, 10.1016/j.ejps.2005.08.003 Lewis, 1998, Review article: the use of biotherapeutic agents in the prevention and treatment of gastrointestinal disease, Aliment. Pharmacol. Ther., 12, 807, 10.1046/j.1365-2036.1998.00386.x Leyden, 1985, Absorption of minocycline hydrochloride and tetracycline hydrochloride: effect of food, milk, and iron, J. Am. Acad. Dermatol., 12, 308, 10.1016/S0190-9622(85)80041-4 Liebler, 2008, Protein damage by reactive electrophiles: targets and consequences, Chem. Res. Toxicol., 21, 117, 10.1021/tx700235t Lin, 2006, CYP induction-mediated drug interactions: in vitro assessment and clinical implications, Pharm. Res., 23, 1089, 10.1007/s11095-006-0277-7 Litou, 2016, Characteristics of the human upper gastrointestinal contents in the fasted state under hypo- and A-chlorhydric gastric conditions under conditions of typical drug – drug interaction studies, Pharm. Res., 33, 1399, 10.1007/s11095-016-1882-8 Lown, 1997, Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression, J. Clin. Invest., 99, 2545, 10.1172/JCI119439 Macheras, 1991, Bioavailability study of a freeze-dried sodium phenytoin-milk formulation, Biopharm. Drug Dispos., 12, 687, 10.1002/bdd.2510120906 Macheras, 1990, Drug binding and solubility in milk, Pharm. Res., 7, 537, 10.1023/A:1015881103340 Marchetti, 2007, Concise review: clinical relevance of drug drug and herb drug interactions mediated by the ABC transporter ABCB1 (MDR1, P-glycoprotein), Oncologist, 12, 927, 10.1634/theoncologist.12-8-927 Marciani, 2001, Effect of meal viscosity and nutrients on satiety, intragastric dilution, and emptying assessed by MRI, Am. J. Physiol. Gastrointest. Liver Physiol., 280, G1227, 10.1152/ajpgi.2001.280.6.G1227 Marciani, 2010, Postprandial changes in small bowel water content in healthy subjects and patients with irritable bowel syndrome, Gastroenterology, 138, 469, 10.1053/j.gastro.2009.10.055 Marciani, 2013, Delayed gastric emptying and reduced postprandial small bowel water content of equicaloric whole meal bread versus rice meals in healthy subjects: novel MRI insights, Eur. J. Clin. Nutr., 67, 754, 10.1038/ejcn.2013.78 Margalef, 2016, Age related differences in the plasma kinetics of flavanols in rats, J. Nutr. Biochem., 10.1016/j.jnutbio.2015.11.007 Markowitz, 2003, Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme, JAMA, 290, 1500, 10.1001/jama.290.11.1500 Matuskova, 2014, Administration of a probiotic can change drug pharmacokinetics: effect of E. coli Nissle 1917 on amidarone absorption in rats, PLoS One, 9, 1, 10.1371/journal.pone.0087150 McCloy, 1984, Duodenal pH in health and duodenal ulcer disease: effect of a meal, Coca-Cola, smoking, and cimetidine, Gut, 25, 386, 10.1136/gut.25.4.386 McEvoy, 1998 McIntosh, 2004, Evaluation of the impact of altered lipoprotein binding conditions on halofantrine induced QTc interval prolongation in an anaesthetized rabbit model, J. Pharm. Pharmacol., 56, 69, 10.1211/0022357022520 McLean, 1978, Food, splanchnic blood flow, and bioavailability of drugs subject to first-pass metabolism, Clin. Pharmacol. Ther., 24, 5, 10.1002/cpt19782415 McLean, 1981, Reduction of first-pass hepatic clearance of propranolol by food, Clin. Pharmacol. Ther., 30, 31, 10.1038/clpt.1981.123 Medicines Evaluation Board in the Netherlands, 2019 Mehvar, 2005, Role of protein binding in pharmacokinetics, Am. J. Pharm. Educ., 69, 10.5688/aj69051526 Merchant, 2016, Age-mediated changes in the gastrointestinal tract, Int. J. Pharm., 512, 382, 10.1016/j.ijpharm.2016.04.024 Mikawlrawng, 2016, Drug interactions, safety and efficacy of probiotics, Asian J. Med. Heal., 1, 1, 10.9734/AJMAH/2016/29244 Mikov, 2018, Potential applications of gliclazide in treating type 1 diabetes mellitus: formulation with bile acids and probiotics, Eur. J. Drug Metab. Pharmacokinet., 43, 269, 10.1007/s13318-017-0441-y Momo, 2004, Drug interaction of tizanidine and fluvoxamine, Clin. Pharmacol. Ther., 76, 509, 10.1016/j.clpt.2004.08.003 Montanari, 2015, Prediction of drug–ABC-transporter interaction — recent advances and future challenges, Adv. Drug Deliv. Rev., 86, 17, 10.1016/j.addr.2015.03.001 Morris, 2006, Flavonoid–drug interactions: effects of flavonoids on ABC transporters, Life Sci., 78, 2116, 10.1016/j.lfs.2005.12.003 Mougey, 2009, Absorption of montelukast is transporter mediated: a common variant of OATP2B1 is associated with reduced plasma concentrations and poor response, Pharmacogenet. Genomics, 19, 129, 10.1097/FPC.0b013e32831bd98c Mouly, 2017, Is the clinical relevance of drug-food and drug-herb interactions limited to grapefruit juice and Saint-John's Wort?, Pharmacol. Res., 118, 82, 10.1016/j.phrs.2016.09.038 Mudie, 2014, Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state, Mol. Pharm., 11, 3039, 10.1021/mp500210c Mueller, 1994, Influence of a fat-rich meal on the pharmacokinetics of a new oral formulation of cyclosporine in a crossover comparison with the market formulation, Pharm. Res., 11, 151, 10.1023/A:1018922517162 Munday, 2012, Harmful and beneficial effects of organic monosulfides, disulfides, and polysulfides in animals and humans, Chem. Res. Toxicol., 25, 47, 10.1021/tx200373u Murphy, 2005, Interaction of St. John's Wort with oral contraceptives: effects on the pharmacokinetics of norethindrone and ethinyl estradiol, ovarian activity and breakthrough bleeding, Contraception, 71, 402, 10.1016/j.contraception.2004.11.004 Murray, 2014, Differential effects of FODMAPs (Fermentable Oligo-, Di-, Mono-Saccharides and Polyols) on small and large intestinal contents in healthy subjects shown by MRI, Am. J. Gastroenterol., 109, 110, 10.1038/ajg.2013.386 Murray, 2017, Magnetic resonance imaging quantification of fasted state colonic liquid pockets in healthy humans, Mol. Pharm., 14, 2629, 10.1021/acs.molpharmaceut.7b00095 Murray, 2006, Altered CYP expression and function in response to dietary factors: potential roles in disease pathogenesis, Curr. Drug Metab., 7, 67, 10.2174/138920006774832569 Murray, 2005, Alcohol-associated rapid release of a long-acting opioid, CMAJ, 173, 10.1503/cmaj.051083 Mwebaza, 2013, Comparable lumefantrine oral bioavailability when co-administered with oil-fortified maize porridge or milk in healthy volunteers, Basic Clin. Pharmacol. Toxicol., 113, 66, 10.1111/bcpt.12065 Naemura, 2008, Long-term intake of rosemary and common thyme herbs inhibits experimental thrombosis without prolongation of bleeding time, Thromb. Res., 122, 517, 10.1016/j.thromres.2008.01.014 Nakamori, 2012, Quantitative prediction of human intestinal glucuronidation effects on intestinal availability of UDP-glucuronosyltransferase substrates using in vitro data, Drug Metab. Dispos., 40, 1771, 10.1124/dmd.112.045476 Nakanishi, 2012, Breast cancer resistance protein (BCRP/ABCG2): its role in multidrug resistance and regulation of its gene expression, Chin. J. Cancer, 31, 73, 10.5732/cjc.011.10320 Nakanishi, 2015, Interaction of drug or food with drug transporters in intestine and liver, Curr. Drug Metab., 16, 753, 10.2174/138920021609151201113537 Nässl, 2011, The intestinal peptide transporter pept1 is involved in food intake regulation in mice fed a high-protein diet, PLoS One, 6, 10.1371/journal.pone.0026407 Neel, 2017, Exploiting non-covalent π interactions for catalyst design, Nature, 543, 637, 10.1038/nature21701 Neuvonen, 1976, Interactions with the absorption of tetracyclines, Drugs, 11, 45, 10.2165/00003495-197611010-00004 Neuvonen, 1991, Interference of dairy products with the absorption of ciprofloxacin, Clin. Pharmacol. Ther., 50, 498, 10.1038/clpt.1991.174 Nicastro, 2015, Garlic and onions: their cancer prevention properties, Cancer Prev. Res., 8, 181, 10.1158/1940-6207.CAPR-14-0172 Niemi, 2007, Role of OATP transporters in the disposition of drugs, Pharmacogenomics, 8, 787, 10.2217/14622416.8.7.787 Noh, 2017, Impact of gut microbiota on drug metabolism: an update for safe and effective use of drugs, Arch. Pharm. Res., 40, 1345, 10.1007/s12272-017-0986-y Nozawa, 2003, Functional characterization of pH-sensitive organic anion transporting polypeptide OATP-B in human, J. Pharmacol. Exp. Ther., 308, 438, 10.1124/jpet.103.060194 Offman, 2001, Red wine-cisapride interaction: comparison with grapefruit juice, Clin. Pharmacol. Ther., 70, 17, 10.1067/mcp.2001.116892 Ogawa, 2011, Clinically significant drug interactions with antacids, Drugs, 71, 1839, 10.2165/11593990-000000000-00000 Ooi, 2015, Effect of dietary fatty acids on human lipoprotein metabolism: a comprehensive update, Nutrients, 7, 4416, 10.3390/nu7064416 O'Shea, 2018, Food for thought: formulating away the food effect - a PEARRL review, J. Pharm. Pharmacol. Paine, 2006, The human intestinal cytochrome P450 “pie”, Drug Metab. Dispos., 34, 880, 10.1124/dmd.105.008672 Pal, 2007, A stomach road or “Magenstrasse” for gastric emptying, J. Biomech., 40, 1202, 10.1016/j.jbiomech.2006.06.006 Paśko, 2017, Second generation H1 - antihistamines interaction with food and alcohol—a systematic review, Biomed. Pharmacother., 10.1016/j.biopha.2017.06.008 Pasricha, 2017, White paper AGA: gastroparesis: clinical and regulatory insights for clinical trials, Clin. Gastroenterol. Hepatol., 15, 1184, 10.1016/j.cgh.2017.04.011 Patel, 2009, The effect of oral lipids and circulating lipoproteins on the metabolism of drugs, Exp. Opin. Drug Metab. Toxicol., 5, 1385, 10.1517/17425250903176439 Patel, 2010, Effect of experimental hyperlipidaemia on the electrocardiographic effects of repeated doses of halofantrine in rats, Br. J. Pharmacol., 161, 1427, 10.1111/j.1476-5381.2010.00983.x Pazianas, 2013, Eliminating the need for fasting with oral administration of bisphosphonates, Ther. Clin. Risk Manag., 9, 395, 10.2147/TCRM.S52291 Pedersen, 2013, Characterization of fasted human gastric fluid for relevant rheological parameters and gastric lipase activities, Eur. J. Pharm. Biopharm., 85, 958, 10.1016/j.ejpb.2013.05.007 Pentafragka, 2018, The impact of food intake on the luminal environment and performance of oral drug products with a view to in vitro and in silico simulations: a PEARRL review, J. Pharm. Pharmacol. Peters, 2016, Predicting drug extraction in the human gut wall: assessing contributions from drug metabolizing enzymes and transporter proteins using preclinical models, Clin. Pharmacokinet., 55, 673, 10.1007/s40262-015-0351-6 Piscitelli, 2002, The effect of garlic supplements on the pharmacokinetics of saquinavir, Clin. Infect. Dis., 34, 234, 10.1086/324351 Porter, 2007, Lipids and lipid-based formulations: optimizing the oral delivery of lipophilic drugs, Nat. Rev. Drug Discov., 6, 231, 10.1038/nrd2197 Randolph, 2014, Lymphatic transport of high-density lipoproteins and chylomicrons, J. Clin. Invest., 124, 929, 10.1172/JCI71610 Ratain, 2007, The value meal: how to save $1,700 per month or more on lapatinib, J. Clin. Oncol., 25, 3397, 10.1200/JCO.2007.12.0758 Rautio, 1999, Liver abscess due to a Lactobacillus rhamnosus strain indistinguishable from L. rhamnosus strain GG, Clin. Infect. Dis., 28, 1159, 10.1086/514766 Reppas, 1993, High viscosity hydroxypropylmethylcellulose reduces postprandial blood glucose concentrations in NIDDM patients, Diabet. Res. Clin. Pr., 22, 61, 10.1016/0168-8227(93)90133-P Reppas, 2015, Characterization of contents of distal ileum and cecum to which drugs/drug products are exposed during bioavailability/bioequivalence studies in healthy adults, Pharm. Res., 32, 3338, 10.1007/s11095-015-1710-6 van Riet-Nales, 2015, Methods of administering oral formulations and child acceptability, Int. J. Pharm., 491, 261, 10.1016/j.ijpharm.2015.06.047 Rodríguez-Fragoso, 2011, Potential risks resulting from fruit/vegetable-drug interactions: effects on drug-metabolizing enzymes and drug transporters, J. Food Sci., 76, R112, 10.1111/j.1750-3841.2011.02155.x Ronis, 2016, Effects of soy containing diet and isoflavones on cytochrome P450 enzyme expression and activity, Drug Metab. Rev., 48, 331, 10.1080/03602532.2016.1206562 Rose, 2017, Incorporation of the time-varying postprandial increase in splanchnic blood flow into a PBPK model to predict the effect of food on the pharmacokinetics of orally administered high-extraction drugs, AAPS J., 19, 1205, 10.1208/s12248-017-0099-z Roth, 2011, Interactions of green tea catechins with organic anion-transporting polypeptides, Drug Metab. Dispos., 39, 920, 10.1124/dmd.110.036640 Rubbens, 2016, Ethanol concentrations in the human gastrointestinal tract after intake of alcoholic beverages, Eur. J. Pharm. Sci., 86, 91, 10.1016/j.ejps.2016.02.009 Ryan, 2014, Nano-chemotherapeutics: maximising lymphatic drug exposure to improve the treatment of lymph-metastatic cancers, J. Control. Release, 193, 241, 10.1016/j.jconrel.2014.04.051 Said Salem, 2017, Modulatory effect of curcumin against genotoxicity and oxidative stress induced by cisplatin and methotrexate in male mice, Food Chem. Toxicol., 105, 370, 10.1016/j.fct.2017.04.007 San Miguel, 2005, Food–drug interactions in the summary of product characteristics of proprietary medicinal products, Eur. J. Clin. Pharmacol., 61, 77, 10.1007/s00228-004-0846-9 Sandberg, 2015, A novel semi-automatic segmentation method for volumetric assessment of the colon based on magnetic resonance imaging, Abdom. Imaging, 40, 2232, 10.1007/s00261-015-0475-z Saputri, 2018, Lactobacillus plantarum IS-10506 probiotic administration increases amlodipine absorption in a rabbit model, J. Int. Med. Res, 46, 5004, 10.1177/0300060518788994 Sauter, 2012, Measuring the interaction of meal and gastric secretion: a combined quantitative magnetic resonance imaging and pharmacokinetic modeling approach, Neurogastroenterol. Motil., 24, 632, 10.1111/j.1365-2982.2012.01916.x Schiller, 2005, Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging, Aliment. Pharmacol. Ther., 22, 971, 10.1111/j.1365-2036.2005.02683.x Schmidt, 2002, Food-drug interactions, Drugs, 62, 1481, 10.2165/00003495-200262100-00005 Schneider, 2016, Resolving the physiological conditions in bioavailability and bioequivalence studies: comparison of fasted and fed state, Eur. J. Pharm. Biopharm., 108, 214, 10.1016/j.ejpb.2016.09.009 Schug, 2002, The effect of food on the pharmacokinetics of nifedipine in two slow release formulations: pronounced lag-time after a high fat breakfast, Br. J. Clin. Pharmacol., 53, 582, 10.1046/j.1365-2125.2002.01599.x Schug, 2002, Formulation-dependent food effects demonstrated for nifedipine modified-release preparations marketed in the European Union, Eur. J. Pharm. Sci., 15, 279, 10.1016/S0928-0987(02)00008-8 Schug, 2002, Dosage form-related food interaction observed in a marketed once-daily nifedipine formulation after a high-fat American breakfast, Eur. J. Clin. Pharmacol., 58, 119, 10.1007/s00228-002-0444-7 Scientific Concepts of Functional Foods in Europe Consensus Document, 1999, Br. J. Nutr., 81, S1, 10.1017/S0007114599000471 Shackleford, 2003, Contribution of lymphatically transported testosterone undecanoate to the systemic exposure of testosterone after oral administration of two andriol formulations in conscious lymph duct-cannulated dogs, J. Pharmacol. Exp. Ther., 306, 925, 10.1124/jpet.103.052522 Shayeganpour, 2005, Pharmacokinetics of amiodarone in hyperlipidemic and simulated high fat-meal rat models, Biopharm. Drug Dispos., 26, 249, 10.1002/bdd.457 Shayeganpour, 2008, The impact of experimental hyperlipidemia on the distribution and metabolism of amiodarone in rat, Int. J. Pharm., 361, 78, 10.1016/j.ijpharm.2008.05.019 Shirasaka, 2013, Major active components in grapefruit, orange, and apple juices responsible for OATP2B1-mediated drug interactions, J. Pharm. Sci., 102, 3418, 10.1002/jps.23653 Shitara, 2013, Clinical significance of organic anion transporting polypeptides (OATPs) in drug disposition: their roles in hepatic clearance and intestinal absorption, Biopharm. Drug Dispos., 34, 45, 10.1002/bdd.1823 Shulman, 1989, Dietary restriction, tyramine, and the use of monoamine oxidase inhibitors, J. Clin. Psychopharmacol., 9, 397, 10.1097/00004714-198912000-00002 Singh, 1999, Effects of food on clinical pharmacokinetics, Clin. Pharmacokinet., 37, 213, 10.2165/00003088-199937030-00003 Smith, 2013, Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications, Mol. Asp. Med., 34, 323, 10.1016/j.mam.2012.11.003 Sousa, 2008, The gastrointestinal microbiota as a site for the biotransformation of drugs, Int. J. Pharm., 363, 1, 10.1016/j.ijpharm.2008.07.009 Sousa, 2014, On the colonic bacterial metabolism of azo-bonded prodrugs of 5-aminosalicylic acid, J. Pharm. Sci., 103, 3171, 10.1002/jps.24103 Sprouse, 2016, Pharmacokinetic interactions between drugs and botanical dietary supplements, Drug Metab. Dispos., 44, 162, 10.1124/dmd.115.066902 Sridar, 2004, Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases, Drug Metab. Dispos., 32, 587, 10.1124/dmd.32.6.587 Stearns, 2017, Ethnic and diet-related differences in the healthy infant microbiome, Genome Med, 9, 10.1186/s13073-017-0421-5 Stebler, 1990, Binding of drugs in milk: the role of casein in milk protein binding, Pharm. Res., 7, 633, 10.1023/A:1015826413335 Stegemann, 2012, Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy, Int. J. Pharm., 430, 197, 10.1016/j.ijpharm.2012.04.022 Steingoetter, 2015, Volume, distribution and acidity of gastric secretion on and off proton pump inhibitor treatment: a randomized double-blind controlled study in patients with gastro-esophageal reflux disease (GERD) and healthy subjects, BMC Gastroenterol., 15, 1, 10.1186/s12876-015-0343-x Stieger, 2017, Intestinal and hepatocellular transporters: therapeutic effects and drug interactions of herbal supplements, Ann. Rev. Pharmacol. Toxicol., 57, 399, 10.1146/annurev-pharmtox-010716-105010 Stojkovic, 2014, A case study of in silico modelling of ciprofloxacin hydrochloride/metallic compound interactions, AAPS PharmSciTech, 15, 270, 10.1208/s12249-013-0055-x Stotzer, 2000, Human postprandial gastric emptying of indigestible solids can occur unrelated to antral phase III, Neurogastroenterol. Motil., 12, 415, 10.1046/j.1365-2982.2000.00218.x Takano, 2006, Expression and function of efflux drug transporters in the intestine, Pharmacol. Ther., 109, 137, 10.1016/j.pharmthera.2005.06.005 Tamai, 2012, Oral drug delivery utilizing intestinal OATP transporters, Adv. Drug Deliv. Rev., 64, 508, 10.1016/j.addr.2011.07.007 Tannergren, 2004, St John's wort decreases the bioavailability of R- and S-verapamil through induction of the first-pass metabolism, Clin. Pharmacol. Ther., 75, 298, 10.1016/j.clpt.2003.12.012 Tanno, 2008, Site-specific drug delivery to the middle-to-lower region of the small intestine reduces food–drug interactions that are responsible for low drug absorption in the fed state, J. Pharm. Sci., 97, 5341, 10.1002/jps.21382 Tapaninen, 2010, Grapefruit juice greatly reduces the plasma concentrations of the OATP2B1 and CYP3A4 substrate aliskiren, Clin. Pharmacol. Ther., 88, 339, 10.1038/clpt.2010.101 Tognolini, 2006, Comparative screening of plant essential oils: phenylpropanoid moiety as basic core for antiplatelet activity, Life Sci., 78, 1419, 10.1016/j.lfs.2005.07.020 Trevaskis, 2006, An examination of the interplay between enterocyte-based metabolism and lymphatic drug transport in the rat, Drug Metab. Dispos., 34, 729, 10.1124/dmd.105.008102 Trevaskis, 2008, Lipid-based delivery systems and intestinal lymphatic drug transport: a mechanistic update, Adv. Drug Deliv. Rev., 60, 702, 10.1016/j.addr.2007.09.007 Trevaskis, 2009, Intestinal lymphatic transport enhances the post-prandial oral bioavailability of a novel cannabinoid receptor agonist via avoidance of first-pass metabolism, Pharm. Res., 26, 1486, 10.1007/s11095-009-9860-z Trevaskis, 2010, Targeted drug delivery to lymphocytes: a route to site-specific immunomodulation?, Mol. Pharm., 7, 2297, 10.1021/mp100259a Trevaskis, 2010, The role of the intestinal lymphatics in the absorption of two highly lipophilic cholesterol ester transfer protein inhibitors (CP524,515 and CP532,623), Pharm. Res., 27, 878, 10.1007/s11095-010-0083-0 Trevaskis, 2010, The mechanism of lymphatic access of two cholesteryl ester transfer protein inhibitors (CP524,515 and CP532,623) and evaluation of their impact on lymph lipoprotein profiles, Pharm. Res., 27, 1949, 10.1007/s11095-010-0199-2 Trevaskis, 2013, A mouse model to evaluate the impact of species, sex, and lipid load on lymphatic drug transport, Pharm. Res., 30, 3254, 10.1007/s11095-013-1000-0 Trevaskis, 2015, From sewer to saviour — targeting the lymphatic system to promote drug exposure and activity, Nat. Rev. Drug Discov., 14, 781, 10.1038/nrd4608 Tsai, 2012, Evaluation of documented drug interactions and contraindications associated with herbs and dietary supplements: a systematic literature review, Int. J. Clin. Pr., 66, 1056, 10.1111/j.1742-1241.2012.03008.x Tsui, 1989, The effect of dietary protein on the efficacy of l-dopa: a double-blind study, Neurology, 39, 10.1212/WNL.39.4.549 Tuleu, 2007, A scintigraphic investigation of the disintegration behaviour of capsules in fasting subjects: a comparison of hypromellose capsules containing carrageenan as a gelling agent and standard gelatin capsules, Eur. J. Pharm. Sci., 30, 251, 10.1016/j.ejps.2006.11.008 Uesugi, 2006, Effect of intestinal CYP3A5 on postoperative tacrolimus trough levels in living-donor liver transplant recipients, Pharmacogenet. Genomics, 16, 119, 10.1097/01.fpc.0000184953.31324.e4 Uivarosi, 2013, Metal complexes of quinolone antibiotics and their applications: an update, Molecules, 18, 11153, 10.3390/molecules180911153 Van Den Abeele, 2017, Exploring the link between gastric motility and intragastric drug distribution in man, Eur. J. Pharm. Biopharm., 112, 75, 10.1016/j.ejpb.2016.10.027 Van Den Abeele, 2017, The dynamic gastric environment and its impact on drug and formulation behaviour, Eur. J. Pharm. Sci., 96, 207, 10.1016/j.ejps.2016.08.060 Varum, 2010, Oral modified-release formulations in motion: the relationship between gastrointestinal transit and drug absorption, Int. J. Pharm., 395, 26, 10.1016/j.ijpharm.2010.04.046 Varum, 2013, Food, physiology and drug delivery, Int. J. Pharm., 457, 446, 10.1016/j.ijpharm.2013.04.034 Vertzoni, 2012, Luminal lipid phases after administration of a triglyceride solution of danazol in the fed state and their contribution to the flux of danazol across Caco-2 cell monolayers, Mol. Pharm., 9, 1189, 10.1021/mp200479f Wagner, 2001, Intestinal drug efflux: formulation and food effects, Adv. Drug Deliv. Rev., 50, S13, 10.1016/S0169-409X(01)00183-1 Walstra, 2006 Wasan, 2008, Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery, Nat. Rev. Drug Discov., 7, 84, 10.1038/nrd2353 Weitschies, 2005, Impact of the intragastric location of extended release tablets on food interactions, J. Control. Release, 108, 375, 10.1016/j.jconrel.2005.08.018 Weitschies, 2010, Magnetic marker monitoring: high resolution real-time tracking of oral solid dosage forms in the gastrointestinal tract, Eur. J. Pharm. Biopharm., 74, 93, 10.1016/j.ejpb.2009.07.007 Welling, 1976, Bioavailability of tetracycline and doxycycline in fasted and nonfasted subjects, Antimicrob. Agents Chemother., 11, 462, 10.1128/AAC.11.3.462 Welty, 1994, The temporal effect of food on tacrine bioavailability, J. Clin. Pharmacol., 34, 985, 10.1002/j.1552-4604.1994.tb01970.x White, 2009, Lymphatic transport of methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU, J. Pharmacol. Exp. Ther., 331, 700, 10.1124/jpet.109.154542 Wilkinson-Smith, 2018, Insights into the different effects of food on intestinal secretion using magnetic resonance imaging, JPEN J. Parenter. Enter. Nutr., 1 Willemsen, 2016, Effect of food and acid-reducing agents on the absorption of oral targeted therapies in solid tumors, Drug Discov. Today, 21, 962, 10.1016/j.drudis.2016.03.002 Williams, 2013, Strategies to address low drug solubility in discovery and development, Pharmacol. Rev., 65, 315, 10.1124/pr.112.005660 Wilson, 1988, Assessment of disintegration and dissolution of dosage forms in vivo using gamma scintigraphy, Drug Dev. Ind. Pharm., 14, 211, 10.3109/03639048809151971 Wilson, 2017, Gut microbiome interactions with drug metabolism, efficacy, and toxicity, Transl. Res., 179, 204, 10.1016/j.trsl.2016.08.002 Won, 2012, Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport, Pharmacol. Ther., 136, 186, 10.1016/j.pharmthera.2012.08.001 Woodbury, 2016, Garlic-induced surgical bleeding: how much is too much?, A A Case Rep, 7, 266, 10.1213/XAA.0000000000000403 Wu, 1995, Differentiation of absorption and first-pass gut and hepatic metabolism in humans: studies with cyclosporine, Clin. Pharmacol. Ther., 58, 492, 10.1016/0009-9236(95)90168-X Xiao, 2010, Antibiotic susceptibility of bifidobacterial strains distributed in the Japanese market, Biosci. Biotechnol. Biochem., 74, 336, 10.1271/bbb.90659 Xiong, 2015, Garlic for hypertension: a systematic review and meta-analysis of randomized controlled trials, Phytomedicine, 22, 352, 10.1016/j.phymed.2014.12.013 Yamamoto, 2017, VLDL/LDL acts as a drug carrier and regulates the transport and metabolism of drugs in the body, Sci. Rep., 7, 10.1038/s41598-017-00685-9 Yamasaki, 2013, Albumin–drug interaction and its clinical implication, Biochim. Biophys. Acta, 1830, 5435, 10.1016/j.bbagen.2013.05.005 Yamasaki, 2017, Long chain fatty acids alter the interactive binding of ligands to the two principal drug binding sites of human serum albumin, PLoS One, 12, 10.1371/journal.pone.0180404 Yoshida, 2013, Hepatic and intestinal drug transporters: prediction of pharmacokinetic effects caused by drug-drug interactions and genetic polymorphisms, Ann. Rev. Pharmacol. Toxicol., 53, 581, 10.1146/annurev-pharmtox-011112-140309 van Zanden, 2007, The effect of quercetin phase II metabolism on its MRP1 and MRP2 inhibiting potential, Biochem. Pharmacol., 74, 345, 10.1016/j.bcp.2007.04.002 Zgair, 2017, Oral administration of cannabis with lipids leads to high levels of cannabinoids in the intestinal lymphatic system and prominent immunomodulation, Sci. Rep., 7, 10.1038/s41598-017-15026-z Zhou, 2004, Pharmacokinetic interactions of drugs with St John's Wort, J. Psychopharmacol., 18, 262, 10.1177/0269881104042632 Ziółkowski, 2016, Metal ion-oxytetracycline pharmacokinetic interactions after oral co-administration in broiler chickens, Poult. Sci., 95, 1927, 10.3382/ps/pew121